Showing results (101-110 of 128) with videos related to
Sort By:
Pageof 13
Aging Cell|January 17, 2020
The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retinaDaniel Chen, Daniel L Chao, Lorena Rocha, et al.Molecular Cell|April 23, 2016
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLAAndrew M Gross, Philipp A Jaeger, Jason F Kreisberg, et al.Plos Genetics|April 6, 2006
PRKCA and multiple sclerosis: association in two independent populationsJanna Saarela, Suvi P Kallio, Daniel Chen, et al.Journal of Psychopathology and Clinical Science|March 20, 2025
Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record dataNicholas A Livingston, Amar D Mandavia, Anne N Banducci, et al.Elife|June 9, 2023
Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domainElizabeth L Wagner, Jun-Sub Im, Stefano Sala, et al.Frontiers in Immunology|April 9, 2025
AI discovery of TLR agonist-driven phenotypes reveals unique features of peripheral cells from healthy donors and ART-suppressed people living with HIVRobert Were Omange, Samuel C Kim, Nikita S Kolhatkar, et al.Advanced Biology|October 16, 2023
Microphysiological Models of Lung Epithelium-Alveolar Macrophage Co-Cultures to Study Chronic Lung DiseaseDave A Lagowala, Arabelis Wally, Kai Wilmsen, et al.The Oncologist|March 10, 2017
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal CancerRocío García-Carbonero, Eric van Cutsem, Fernando Rivera, et al.BMJ Open|February 5, 2025
HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunctionBenjamin Dowsing, Hakim-Moulay Dehbi, Robin Chung, et al.Communications Biology|October 30, 2022
Loss of E-cadherin is causal to pathologic changes in chronic lung diseaseBaishakhi Ghosh, Jeffrey Loube, Shreeti Thapa, et al.Pageof 13